Quantcast
Last updated on April 24, 2014 at 14:12 EDT

Latest Protein expression Stories

2014-04-24 12:24:32

DALLAS, April 24, 2014 /PRNewswire/ -- According to the new market research report "Protein Expression Market by Products (Expression Vector, Service, Reagent), Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast), Application (Industrial, Therapeutic), End User (Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018" published by MarketsandMarkets, The global Protein Expression Market is expected to grow at a CAGR of 8.83% between 2013 and 2018, to reach...

2013-12-19 23:23:22

St. George’s to Utilize DNA2.0’s GeneGPS® Expression Technology to Increase Protein Expression in Tobacco for the Production of Therapeutic Antibodies Menlo Park, Calif. (PRWEB) December 19, 2013 DNA2.0 has entered into a research collaboration with the Infection and Immunity Research Centre at St. George’s, University of London, to support the development of plant-based biopharmaceuticals. Professor Julian Ma and his research group at St. George’s have made significant...

2013-12-17 23:04:19

CSO to Present Data on the Recently Launched SURE CHO-Mplus™ Libraries Geneva, Switzerland (PRWEB) December 17, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs announced today data from the Company’s SURE CHO-Mplus™ Libraries will be presented at the 13th Annual PepTalk Conference, January 13-17, 2014 at the Renaissance Hotel & Palm Springs...

2013-04-17 23:04:13

Technology Addresses Secretion Bottlenecks in Recombinant Protein Expression. Geneva, Switzerland (PRWEB) April 17, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification, cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today the launch of its novel platform, SURE CHO-Mplus Libraries, which were designed and constructed to address a broad range of issues surrounding recombinant protein secretion including...

2012-10-19 07:23:25

MOUNTAIN VIEW, Calif., Oct. 19, 2012 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., is honored to receive the RUSNANOPRIZE 2012 together with Dr. Sergey Lukyanov, for the innovation "Fluorescent proteins of coral polyps: discovery and use in biotechnology". The RUSNANOPRIZE is a major international award for nanotechnology discoveries and innovations that was established by the Russian Corporation of Nanotechnologies (RUSNANO) in 2009....

2011-02-24 00:00:45

The National Science Foundation grant"”administered through the Small Business Innovation Research Program (SBIR)"”will enable DNA2.0 to extend the company's proven gene optimization technology to production hosts for human therapeutics. Menlo Park, CA (PRWEB) February 23, 2011 DNA2.0, the leading gene synthesis and protein engineering company, has been awarded a National Science Foundation (NSF) grant to further the company's research into gene optimization algorithms for...

2010-01-07 09:00:00

IPSWICH, Mass., Jan. 7 /PRNewswire/ -- New England Biolabs (NEB) has introduced Lemo21(DE3) Competent E. coli, a tunable T7 expression strain optimized for the expression of difficult constructs, including membrane proteins, toxic proteins and proteins prone to insoluble expression. A derivative of BL21(DE3), Lemo21(DE3) offers the host features of this commonly used expression strain, with the added benefit of being able to finely tune T7 expression. Tunable expression is achieved by...